Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$472,579
+$63,263 QoQ
Shares Held
1,878
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#3,218
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $11,041,030 across 10 Drug Manufacturers - General names. ABBV ranks #2 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,159 | $9,786,150 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,878 | $472,579 | |
| 3 | JNJ |
Johnson & Johnson
|
1,205 | $306,033 | |
| 4 | AMGN |
Amgen Inc
|
372 | $134,708 | |
| 5 | MRK |
Merck & Co., Inc.
|
980 | $125,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392 | $80,207 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
463 | $58,495 | |
| 8 | BIIB |
Biogen Inc.
|
152 | $32,841 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,579 | 1,878 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $409,316 | 1,882 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $430,932 | 1,886 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $448,956 | 1,939 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $296,063 | 1,595 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $329,784 | 1,574 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $217,327 | 1,223 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $241,518 | 1,223 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $199,134 | 1,161 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $211,418 | 1,161 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $197,741 | 1,276 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $175,294 | 1,176 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $156,421 | 1,161 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $185,028 | 1,161 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $187,629 | 1,161 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $155,817 | 1,161 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $177,818 | 1,161 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $188,209 | 1,161 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $157,199 | 1,161 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $125,237 | 1,161 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $130,775 | 1,161 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $125,643 | 1,161 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $124,401 | 1,161 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $101,691 | 1,161 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $113,986 | 1,161 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $88,456 | 1,161 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||